These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35070423)

  • 21. Coiled-Coil Domain-Containing Protein 45 Is a Potential Prognostic Biomarker and Is Associated with Immune Cell Enrichment of Hepatocellular Carcinoma.
    Liu S; Jia L; Quan B; Rong G; Li M; Xie R; Cai Y; Bi Y; Han S
    Dis Markers; 2022; 2022():7745315. PubMed ID: 36618966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNTTIP1 is a Prognostic Biomarker Correlated With Immune Infiltrates in Hepatocellular Carcinoma: A Study Based on The Cancer Genome Atlas Data.
    Zhu C; Tong R; Jiang X; Xiao H; Guan J; Shu J
    Front Genet; 2021; 12():767834. PubMed ID: 35265097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints.
    Tang M; Liao M; Ai X; He G
    Front Med (Lausanne); 2021; 8():773724. PubMed ID: 35372372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma.
    Xu W; Huang Y; Mei Y; Zhang Y; Luo Q; Zhu S; Peng L; Gao Z; Liu Y; Li J
    Curr Oncol; 2022 Nov; 29(11):8650-8667. PubMed ID: 36421335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRGBP is a potential novel prognostic biomarker and is correlated with immune infiltrates in hepatocellular carcinoma.
    Huang J; Chen X; Zhu W
    Medicine (Baltimore); 2021 Mar; 100(12):e25234. PubMed ID: 33761715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated Small Nuclear Ribonucleoprotein Polypeptide an Expression Correlated With Poor Prognosis and Immune Infiltrates in Patients With Hepatocellular Carcinoma.
    Zhang Y; Wang X; Wang H; Jiang Y; Xu Z; Luo L
    Front Oncol; 2022; 12():893107. PubMed ID: 35860579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
    Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
    J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
    Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
    Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
    Fang Q; Chen H
    Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Overexpression of Nei endonuclease VIII-like protein 3 in hepatocellular carcinoma indicates increased levels of immune infiltration and an unfavorable prognosis].
    Wang GN; Zhang YP; Wang MC; Han W; Zhang YC
    Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):986-995. PubMed ID: 37872095
    [No Abstract]   [Full Text] [Related]  

  • 34. Immune landscape of hepatocellular carcinoma: The central role of TP53-inducible glycolysis and apoptosis regulator.
    Qiu L; Ma T; Guo Y; Chen J
    Open Med (Wars); 2024; 19(1):20240999. PubMed ID: 39091612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma.
    Cheng S; Li J; Xu M; Bao Q; Wu J; Sun P; Han B
    Anal Cell Pathol (Amst); 2023; 2023():4413049. PubMed ID: 37305689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive Analysis of NABP2 as a Prognostic Biomarker and Its Correlation with Immune Infiltration in Hepatocellular Carcinoma.
    Li B; Liu J; Xu L; Xu Q; Liu Z; Liu T
    J Inflamm Res; 2023; 16():1783-1804. PubMed ID: 37113629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
    Li L; Wang X; Ding Y; Hui N; Su B; Yang M
    Eur J Med Res; 2022 Oct; 27(1):216. PubMed ID: 36307879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of Hepatocellular Carcinoma Prognosis and Immune Cell Infiltration Using Gene Signature Associated with Inflammatory Response.
    Da BB; Luo S; Huang M; Song F; Ding R; Xiao Y; Fu Y; Yang YS; Wang HL
    Comput Math Methods Med; 2022; 2022():2415129. PubMed ID: 35035517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of TBC1D10B as a potential prognostic and immunotherapy relevant biomarker in liver hepatocellular carcinoma.
    Fan L; Tang Y; Li J; Huang W
    Sci Rep; 2023 Jan; 13(1):335. PubMed ID: 36611046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.